Implementation of Comprehensive Geriatric Evaluation for the Care of Patients with Lymphoma

Authors

Abstract

Introduction: Elderly people with cancer must be evaluated differently to define the degree of vulnerability and fragility when facing treatment.

Objective: To implement comprehensive geriatric assessment in patients diagnosed with lymphoma.

Method: A prospective and longitudinal analytical descriptive study was carried out with geriatric patients with diagnosis of lymphoma, enrolled in the Institute of Oncology and Radiobiology, from May 2019 to July 2020. These subjects had a vulnerability index greater than three and underwent a comprehensive geriatric evaluation to define their degree of frailty and risk of toxicity to chemotherapy.

Results: A total of 45 patients were evaluated. The median age was 70 years. 60% had a diagnosis of diffuse large B cell lymphoma. 84.4% of the patients had normal nutritional status. Within the assessment of cognitive status, recent memory loss was the most frequently found disorder. After the comprehensive geriatric evaluation, it was determined that 80% of the elderly were in the pre-frail category according to the age-related chemotherapy risk scale. The low-risk group presented the lowest percentage of patients with grade 3 - 4 toxicity (16.7%).

Conclusions: The comprehensive geriatric evaluation made it possible to detect alterations in the functional, nutritional and cognitive status of the evaluated patients, and to stratify them into risk groups for chemotherapy toxicities and accurately identify the risk of chemotherapy toxicity.

Downloads

Download data is not yet available.

Author Biography

Yanelis Longina Mir Espinosa, Instituto Nacional de Oncología y Radiobiología (INOR

miembro del departamento de oncologia medica.INOR

References

1. Tr1. Trevino KM, Prigerson HG, Shen MJ, et al. Association between ad-

vanced cancer patient-caregiver agreement regarding prognosis and

hospice enrollment. Cancer. 2019;125:3259-65. DOI: 10.1002/cncr.32188

2. OMS. Envejecimiento. Acceso 12/12/2017. Disponible en: https://www.who.int/health-topics/ageing#tab=tab_1

3. Loh KP, Mohile SG, Epstein RM. Willingness to bear adversity

and beliefs about the curability of advanced cancer in older adults.

Cancer. 2019;125:2506-13. DOI: 10.1002/cncr.32074

4. Galán Álvarez Y, Iglesias Ventura Y, KindelánValerino G, Lezcano Cecili M, Grueiro Fernández S, Planas Cancio S. Anuario de incidencia de cáncer en Cuba. 2016. Registro Nacional de Cáncer 2020.

5. Nipp RD, Greer JA, El-Jawahri A. Coping and prognostic aware-

ness in patients with advanced cancer. J Clin Oncol. 2017;35:2551-7. DOI: 10.1200/JCO.2016.71.3404

6. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68(6), 394-424. DOI: 10.3322/caac.21492

7. Palm R, Jünger S, Reuther S, Schwab C, Dichter MN, Holle B, et al. People with dementia in nursing home research: a methodological review of the definition and identification of the study population. BMC Geriatrics. 2016;16:78. DOI: 10.1186/s12877-016-0249-7

8. Tinetti M, Dindo L, Smith CD, Blaum C. Challenges and strategies in patients’ health priorities-aligned decision-making for older adults with multiple chronicconditions. PLoS One. 2019;14:e0218249. DOI: 10.1371/journal.pone.0218249

9. Mohilen SG, Dale W, Somerfield MR, et al. Practical assessment

and management of vulnerabilities in older patients receiving che-

motherapy: ASCO guideline for geriatric oncology. J Clin Oncol.

2018;36:2326-47. DOI: 10.1200/JCO.2018.78.8687

10. Ethun CG, Bilen MA, Jani AB, et al: Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017;67:362-77. DOI: 10.3322/caac.21406

11. Rubentestein LZ, Rubentestein LV. Multidimensional Geriatric Assessment. In: Fillit HM, Rockwood K, Woodhouse K, editors. Brocklehurst´s Textbook of Geriatric Medicine and Gerontology. 8th. ed. Philadelphia: Saunders Elsevier; 2016. p. 213-19.

12. Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001 Dec;49(12):1691-9. DOI: 10.1046/j.1532-5415.2001.49281.x

13. Stokoe JM, Pearce J, Sinha R. R, G-8 and VES-13 scores predict chemotherapy toxicity in older patients with cancer. J Geriatr Oncol. 2012;3:S81. DOI: 10.1016/j.jgo.2012.10.096

14. Lawton MP. Scales to measure competence in every day activities. Psychopharmacol Bull. 1988;24:609-14.

15. Vellas B, Guigoz Y, Garry P, Nourhashemi, Bennahum D, Lauque S, et al. The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients Nutrition. 1999;15(2):116-22 DOI: 10.1016/s0899-9007(98)00171-3

16. Folstein M, Folstein SE, McHugh PR. “Mini-Mental State” a Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of Psychiatric Research. 1975;12(3);189-19.

17. Extermann M, Boler I, Reich R, Lyman G, Brown R, De Felice J, et al. Predicting the Risk of Chemotherapy. Toxicity in Older Patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score. Cancer. 2012;118(13):3377-86. DOI: 10.1002/cncr.26646

18. Extermann M, Chen H, Cantor AB, et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer. 2002;38:1466-73. DOI: 10.1016/s0959-8049(02)00090-4

19. Thieblemont C, Bernard S, Molina T. Management of agressive lymphoma in very elderly patients. Hematological Oncology. 2017;35(S1):49-53. DOI: 10.1002/hon.2413

20. Naito Y, Sasaki H, Takamatsu Y, Kiyomi F, Tamura K. Retrospective analysis of treatment outcomes and geriatric assessment in elderly malignant lymphoma patients. J Clin Exp Hematop. 2016;56(1):43-9. DOI:

10.3960/jslrt.56.43

21. Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, et al. Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group. Journal of Geriatric Oncology. 2020;11:62-8. DOI: 10.1016/j.jgo.2019.03.016

22. Shafi RG, Al-Mansour MM, Kanfar SS, Al Hashmi H, Alsaeed A, Al-Foheidi M, et al. Hodgkin lymphoma outcome: A retrospective study from 3 tertiary centers in Saudi Arabia. Oncol Res Treat. 2017. DOI: 10.1159/000460819

23. Beteta Gámez EJ. Comportamiento clínico y epidemiológico del linfoma de Hodgkin en el departamento de Oncología del Hospital Manuel de Jesús Rivera en el período del primero de enero del 2012 al 31 de diciembre del 2016. Tesis para optar al título de especialista en Pediatría. Universidad Nacional Autónoma de Nicaragua. Managua, Nicaragua. 2018. Disponible en: http://repositorio.unan.edu.ni/id/eprint/10239

24. Batista JL, Birmann BM, Epstein MM, Epidemiology of Hematologic Malignancies, in: Loda M, Mucci LA, Mittelstadt ML, Van Hemelrijck M, Cotter MB (Eds.), Pathology and Epidemiology of Cancer, Springer International Publishing, Cham. 2017, pp. 543–569.

25. Martínez Ávila DR, Benítez Caballero B, González Madruga T, Vázquez Olazabal E, Corrales Otero D, Alfonso Estévez D, et al. Linfoma difuso de células grandes B en pacientes adultos mayores. Revista Cubana de Oncología. 2020;18(2):e_36. https://revoncologia.sld.cu/index.php/onc/article/view/36

26. Yoshida M, Nakao T, Horiuchi M. Analysis of elderly patients with diffuse large B-cell lymphoma: Aggressive therapy is a reasonable approach for ‘unfit’ patients classified by comprehensive geriatric assessment. Eur J Haematol. 2016;96:409-16. DOI: 10.1111/ejh.12608

27. Trebouet A, Marchand T, Lemal R, Broussais-Guillaumot F, Guillermin Y, Monjanel H, et al. Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA. Ann Oncol. 2013;24:2612-8. DOI: 10.1093/annonc/mdt282

28. Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J ClinOncol. 1989;7:1630-6. DOI: 10.1200/JCO.1989.7.11.1630

29. Alonso Mariño OL, Alonso Mariño Al, Miranda Chaviano J. Caracterización clínico-epidemiológica de los linfomas en un período de cinco años en Villa Clara. Medicent Electrón 2015;19(1).13-20 https://medicentro.sld.cu/index.php/medicentro/article/view/1843

30. Din L, Sheikh M, Kosaraju N, Ekstrom Smedby K, Bernatsky S, Berndt SI, et al. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. Genet Epidemiol. 2019;43:844-63. DOI: 10.1002/gepi.22242

31. Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 2018;24:679-90. DOI: 10.1038/s41591-018-0016-8

32. Rosenthal A, Younes A. High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: double hit and triple hit lymphomas and double expressing lymphoma. Blood Rev. 2017;31:37-42. DOI: 10.1016/j.blre.2016.09.004

33. Desvaux García M, Antón Rodríguez A. Factores pronósticos en el linfoma de Hodgkin. Revisión de una serie clínica. Trabajo de fin de grado. Universidad de Valladolid. Valladolid, España. 2019. http://uvadoc.uva.es/handle/10324/36397

34. Reuben DB. Evaluación geriátrica. In:Goldman-Cecil. Tratado de medicina interna Expert Consult. 25a. ed. Madrid: Elsevier; 2017.p.102-6. Disponible en http://www.medisur.sld.cu/index.php/medisur/article/view/4009

35. Rubenstein L, Harper J, Salva A,Guigoz Y,Vellas B.Undernutrition in Geriatric Practice:developingthe Short –formMini –Nutritional Assesment .Journal of gerontology. Medical Sciences. 2001;56(6):366-72. DOI: 10.1093/gerona/56.6.m366

36. Makgoeng SB, Bolanos RS, Jeon CY, Weiss RE, Arah OA, Breen EC, Martínez-Maza O, Hussain SK, Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta- Analysis of Prospective Studies, JNCI Cancer Spectr . 2018;2(4):pky082.

DOI: 10.1093/jncics/pky082

37. Zazeira HC. Valoración geriátrica oncológica en la predicción de quimiotoxicidad en cáncer no hematológico hospital nacional Alberto Sabogal Sologuren 2019-202. Proyecto de investigación para optar el título de segunda especialidad en geriatría: Lima, Peru: Universidad San Martin de Porres; 2020. Disponible en http://creativecommons.org/licenses/by-nc-sa/4.0/

38. Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol. 2005;23:6865-72. DOI: 10.1200/JCO.2005.02.527

39. Dent E, Wright O, Hoogendijk EO, Hubbard RE. Nutritional screening and dietitian consultation rates in a geriatric evaluation and management unit. Nutr Diet. 2018;75(1):11-6. DOI: 10.1111/1747-0080.12391

40. Arranz Martínez M, Molina Azorín C, Gómez Mateos C, Gómez Udías N, Santos Boya T. Relación entre el test Mini Nutritional Assessment y el parámetro antropométrico Índice de Masa Corporal en población mayor de 65 años. Prevalencia de malnutrición. RqR Enfermería Comunitaria (Revista de SEAPA). 2017;5(4):6-19. https://dialnet.unirioja.es/servlet/articulo?codigo=6224479

41. Grossberg GT, Beck D, Noman S. Rapid depression assessment in geriatric patients. Clin Geriatr Med. 2017;33(3):383-91. DOI: 10.1016/j.cger.2017.03.007

42. Hurria A, Mohile S, Gajra A, Klepin H, Muss H, Chapman A, et al. Validation of a prediction tool for chemotherapy toxicity in older adults with Cancer. J Clin Oncol. 2016;34:2366-71. DOI: 10.1200/JCO.2015.65.4327

43. Anca Prica, Vinita Dhir, Manjula Maganti, Vishal Kukreti, John Kuruvilla, Michael Crump; Functional Predictors of Chemotherapy Toxicity in Elderly Lymphoma Patients: A Prospective Pilot Study. Blood. 2018;132(Supplement 1):4843. DOI: 10.1182/blood-2018-99-115400

44. Trarieux-Signol S, Fargeas JB, Abraham J, Olivrie A, Picat MA, Signol N, et al. Crash score in the older french non-Hodgkin lymphoma receiving chemotherapy, feasability. SIOG Poster Abstracts 2013. DOI: 10.1016/j.foodchem.2013.09.083

Downloads

Published

2023-12-11

How to Cite

1.
Mir Espinosa YL, Ojeada Pacheco E, Martinez Avila DR, Benítez Caballero B, González Madruga T, Vázquez Olazabal E, et al. Implementation of Comprehensive Geriatric Evaluation for the Care of Patients with Lymphoma. Rev Cub Oncol [Internet]. 2023 Dec. 11 [cited 2025 Jul. 12];20(2). Available from: https://revoncologia.sld.cu/index.php/onc/article/view/189

Issue

Vol. 20 No. 2 (2022): mayo-agosto

Section

Artículos Originales

License

Esta revista provee acceso libre e inmediato a su contenido bajo el principio de que hacer disponible gratuitamente la investigación al público apoya a un mayor intercambio de conocimiento global.

Esto significa que se permite su copia y distribución por cualquier medio siempre que mantenga el reconocimiento de sus autores, no haga uso comercial de las obras y no realice ninguna modificación de ellas.

El envío de manuscritos, el procesamiento y la publicación no ofrece ningún coste a los autores, es totalmente gratis.